|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Clinical Trials
|
NIDDK
|
1U01DK074035-01
|
|
New Diagnosis and Treatment Approaches for Patients wit*
|
MCCALLUM, RICHARD
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$169,454
|
|
Clinical Trials
|
NIAID
|
1U01AI069420-01
|
|
Sao Paulo Clinical Trials Unit
|
KALLAS, ESPER
|
UNIVERSIDADE FEDERAL DE SAO PAULO
|
BRAZIL
|
$493,116
|
|
Clinical Trials
|
NIAID
|
1U01AI069476-01
|
|
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)
|
GRINSZTEJN, BEATRIZ
|
FUNDACAO OSWALDO CRUZ
|
BRAZIL
|
$3,194,471
|
|
Clinical Trials
|
NIAID
|
1U01AI069480-01
|
|
Clinical Trial Unit for HIV Prevention and Microbicide Research
|
MAYER, KENNETH
|
FENWAY COMMUNITY HEALTH CENTER
|
MA
|
$637,625
|
|
Clinical Trials
|
NIMH
|
5R01MH069619-04
|
|
Are Cognitive Therapy's Antidepressant Effects Durable?
|
JARRETT, ROBIN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$342,752
|
|
Clinical Trials
|
NIDDK
|
4R33DK070341-03
|
|
Novel Therapies for Resistant FSGS
|
TRACHTMAN, HOWARD
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$751,294
|
|
Clinical Trials
|
NHLBI
|
5R44HL073591-05
|
|
Clinical Development a Therapeutic Agent for COPD
|
PARIKH, INDU
|
BIOMARCK PHARMACEUTICALS, LTD
|
NC
|
$1,000,000
|
|
Clinical Trials
|
NCI
|
5R01CA106316-05
|
|
Intervention to Prevent Onset of Smoking in Childhood
|
JACKSON, CHRISTINE
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$191,573
|
|
Clinical Trials
|
NCI
|
1R01CA120958-01A1
|
|
Promoting Tobacco Control Among Teachers in India
|
SORENSEN, GLORIAN
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$623,465
|
|
Clinical Trials
|
NIMH
|
1R01MH076829-01A1
|
|
Treating Older Patients with Major Depression and Severe COPD
|
ALEXOPOULOS, GEORGE
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$353,058
|
|
Clinical Trials
|
NIMH
|
5R01MH072556-03
|
|
The STIRR Intervention for Dually Diagnosed Clients
|
ROSENBERG, STANLEY
|
DARTMOUTH COLLEGE
|
NH
|
$553,218
|
|
Clinical Trials
|
NIDA
|
5R01DA018697-04
|
|
Cognitive Rehabilitation for Substance Abusers
|
FALS-STEWART, WILLIAM
|
UNIVERSITY OF ROCHESTER
|
NY
|
$387,297
|
|
Clinical Trials
|
NHLBI
|
5R01HL068706-04
|
|
Project on TRAC: Improving Asthma Control in Children
|
HARVER, ANDREW
|
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
|
NC
|
$417,711
|
|
Clinical Trials
|
NCI
|
5U01CA114591-04
|
|
WINCART: Weaving an Islander Network for Cancer Control
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
CA
|
$509,769
|
|
Clinical Trials
|
NIDA
|
5R01DA019992-04
|
|
Valproate Efficacy in Cocaine-Bipolar Comorbidity
|
SALLOUM, IHSAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$554,487
|
|
Clinical Trials
|
NINDS
|
5K24NS044250-06
|
|
Immunopathogenesis of Multiple Sclerosis
|
RACKE, MICHAEL
|
OHIO STATE UNIVERSITY
|
OH
|
$128,911
|
|
Clinical Trials
|
NIDA
|
5R01DA019434-04
|
|
Group-Based Couples Therapy for Drug Abuse
|
FALS-STEWART, WILLIAM
|
UNIVERSITY OF ROCHESTER
|
NY
|
$319,651
|
|
Clinical Trials
|
NIDA
|
5R01DA016603-06
|
|
Treatment Outcome with Runaway Adolescents II
|
SLESNICK, NATASHA
|
OHIO STATE UNIVERSITY
|
OH
|
$307,074
|
|
Clinical Trials
|
NIDDK
|
5U01DK066013-03
|
|
Live Unrelated Kidney Donor & Sibling Follow-up Study
|
KASISKE, BERTRAM
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$429,448
|
|
Clinical Trials
|
NIDA
|
5R01DA015832-04
|
|
Maternal Opioid Treatment: Human Experimental Research
|
STINE, SUSAN
|
WAYNE STATE UNIVERSITY
|
MI
|
$432,458
|
|
Clinical Trials
|
NIDA
|
5R01DA015741-04
|
|
Maternal Opioid Treatment: Human Experimental Research
|
SELBY, PETER
|
ST. JOSEPH'S HEALTH CENTRE
|
CANADA
|
$200,710
|
|
Clinical Trials
|
NIDA
|
5R01DA015713-04
|
|
Maternal Opioid Treatment: Human Experimental Research
|
MARTIN, PETER
|
VANDERBILT UNIVERSITY
|
TN
|
$668,774
|
|
Clinical Trials
|
NHLBI
|
5R01HL074103-05
|
|
Behavioral Treatment of High Blood Pressure
|
BLUMENTHAL, JAMES
|
DUKE UNIVERSITY
|
NC
|
$709,886
|
|
Clinical Trials
|
NCI
|
4R37CA054281-16
|
|
Multiethnic Cohort Study of Diet and Cancer
|
KOLONEL, LAURENCE
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$2,292,128
|
|
Clinical Trials
|
NCMHD
|
5U01HL073286-05
|
|
Dietary Macronutrients and Weight Loss
|
SACKS, FRANK
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$47,560
|
|
Clinical Trials
|
NHLBI
|
5U01HL073286-05
|
|
Dietary Macronutrients and Weight Loss
|
SACKS, FRANK
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$662,200
|
|
Clinical Trials
|
NIDA
|
2R44DA020975-02
|
|
The DBT-SUD In-Session Response to Dysfunctional Behavior for ACT Teams
|
DIMEFF, LINDA
|
BEHAVIORAL TECH RESEARCH, INC.
|
WA
|
$498,133
|
|
Clinical Trials
|
NIMH
|
5R34MH075628-03
|
|
Preventing HIV & Drug Use Among Juvenile Offenders
|
DONENBERG, GERI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$228,311
|
|
Clinical Trials
|
NIDA
|
1R03DA023393-01
|
|
Behavioral activation and HIV risk reduction for MSM with crystal meth abuse
|
MIMIAGA, MATTHEW
|
FENWAY COMMUNITY HEALTH CENTER
|
MA
|
$75,350
|
|
Clinical Trials
|
NIDA
|
5K05DA000454-08
|
|
Comorbidity in Cocaine and Opioid Pharmacotherapy
|
KOSTEN, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$126,360
|
|
Clinical Trials
|
NIDA
|
5R01DA022276-02
|
|
Glycine Transport Inhibition for Nicotine Dependence in Schizophrenia
|
EVINS, A.
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$333,803
|
|
Clinical Trials
|
NIDA
|
5R01DA020752-02
|
|
GABA Medications for Tobacco Addiction
|
SOFUOGLU, MEHMET
|
YALE UNIVERSITY
|
CT
|
$182,426
|
|
Clinical Trials
|
NIMH
|
5R34MH078874-02
|
|
Randomized Trial of an Online Early Intervention for Combat PTSD in Primary Care
|
ENGEL, CHARLES
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$270,310
|
|
Clinical Trials
|
NIAAA
|
5F31AA016256-02
|
|
A Brief Computer-Based Intervention for Alcohol Use During Pregnancy
|
TZILOS, GOLFO
|
WAYNE STATE UNIVERSITY
|
MI
|
$31,304
|
|
Clinical Trials
|
NIDA
|
1R01DA023651-01
|
|
Extended-Release Mixed Amphetamine Salts for Adults ADHD and Cocaine Dependence
|
GRABOWSKI, JOHN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$403,498
|
|
Clinical Trials
|
NICHD
|
3U10HD053089-02S1
|
|
Incidence & management of hypotension in ill term & near-term infants in the NRN
|
WATTERBERG, KRISTI
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$37,632
|
|
Clinical Trials
|
NCMHD
|
2P20MD000170-06
|
8811
|
COMMUNITY ENGAGEMENT CORE
|
REININGER, BELINDA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$46,378
|
|
Clinical Trials
|
NCMHD
|
2P20MD000170-06
|
0005
|
SOUTH TEXAS PARENT DIABETES PREVENTION TRAIL (STPDPT)
|
KELDER, STEVEN
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$518,712
|
|
Clinical Trials
|
NCCAM
|
1R21AT003400-01A2
|
|
The Use of VSL#3 in Irritable Bowel Syndrome in Children
|
MICHAIL, SONIA
|
WRIGHT STATE UNIVERSITY
|
OH
|
$189,000
|
|
Clinical Trials
|
NCMHD
|
2P60MD000206-06
|
0001
|
Northern Manhattan diabetes community health
|
CARRASQUILO, OLVEEN%
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$897,587
|
|
Clinical Trials
|
NCMHD
|
2P60MD000206-06
|
0003
|
Counseling older Americans to control hypertension (COACH)
|
OGEDEGBE, GBENGA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$969,469
|
|
Clinical Trials
|
NCCAM
|
1R21AT003204-01A2
|
|
THE ROLE OF GUT-DIRECTED HYPNOTHERAPY IN RELAPSE PREVENTION FOR ULCERATIVE COLITI
|
KEEFER, LAURIE
|
NORTHWESTERN UNIVERSITY
|
IL
|
$196,300
|
|
Clinical Trials
|
NIMH
|
5K23MH067702-05
|
|
Cognition and Treatment Outcomes of Geriatric Depression
|
MURPHY, CHRISTOPHER
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$157,311
|
|
Clinical Trials
|
NIMH
|
5K23MH069629-05
|
|
S-Adenosyl Methionine(SAMe)Augmentation of SSRIs in MDD
|
PAPAKOSTAS, GEORGE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$178,166
|
|
Clinical Trials
|
NIMH
|
5R01MH063630-08
|
|
Reducing Risks for Multicultural HIV+/- Women & Partners
|
WEISS, STEPHEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$606,615
|
|
Clinical Trials
|
NIDDK
|
2K24DK063214-06
|
|
Renal blood flow, vascular stiffness, and the DASH diet
|
CONLIN, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$193,458
|
|
Clinical Trials
|
NIDA
|
1K23DA019914-01A2
|
|
Efficacy of Group Treatment for Hispanic Adolescents
|
BURROW-SANCHEZ, JASON
|
UNIVERSITY OF UTAH
|
UT
|
$150,587
|
|
Clinical Trials
|
NIA
|
2R01AG023178-04
|
|
Propensity Scores and Preventive Drug Use in the Elderly
|
STURMER, TIL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$342,007
|
|
Clinical Trials
|
NIAAA
|
4R37AA014028-07
|
|
Duloxetine versus Pregabalin for Treatment of Alcohol Dependence
|
MASON, BARBARA
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$601,297
|
|
Clinical Trials
|
NIMH
|
5K23MH069375-05
|
|
Intimate Partner Violence and Mental Health Symptoms
|
HOURY, DEBRA
|
EMORY UNIVERSITY
|
GA
|
$151,120
|
|
Clinical Trials
|
NIMH
|
5K23MH067894-05
|
|
DEPRESSION DIAGNOSIS AND TREATMENT IN PARKINSON DISEASE
|
WEINTRAUB, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$179,740
|
|
Clinical Trials
|
NIMH
|
5K23MH067779-05
|
|
Psychotherapy for Depressed Primary Care Patients
|
UEBELACKER, LISA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
RI
|
$181,138
|
|
Clinical Trials
|
NIMH
|
5R01MH067948-05
|
|
MENTAL HEALTH OUTCOMES OF PBIS WHOLE SCHOOL INTERVENTIONS
|
LEAF, PHILIP
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$293,057
|
|
Clinical Trials
|
NCI
|
5R01CA114567-03
|
|
Targeted therapy in ex vivo medulloblastoma/PNET
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$223,417
|
|
Clinical Trials
|
NIMH
|
5R01MH067902-05
|
|
DVD Consent for Research in Older Schizophrenia Patients
|
JESTE, DILIP
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$443,824
|
|
Clinical Trials
|
NINR
|
5R01NR009430-03
|
|
Fathers Experience with Pediatric End-of-Life Care
|
DAVIES, ELIZABETH
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$382,083
|
|
Clinical Trials
|
NIAAA
|
1R01AA016017-01A2
|
|
Teachable Moments: Using a BMI with underage drivers to reduce DWI re-offenses
|
C'DE BACA, JANET
|
BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX
|
NM
|
$321,300
|
|
Clinical Trials
|
NINR
|
5F31NR009750-03
|
|
Weight Loss Maintenance: Exploring Racial Differences
|
WARZISKI, MELANIE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$34,045
|
|
Clinical Trials
|
NHLBI
|
5K99HL088021-02
|
|
Impact of Comorbidities on Outcomes of Allogeneic Transplantation
|
SORROR, MOHAMED
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$88,973
|
|
Clinical Trials
|
NIMH
|
5R34MH070827-04
|
|
Treatment for Posttraumatic Stress Disorder in Children
|
SCHEERINGA, MICHAEL
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$190,087
|
|
Clinical Trials
|
NHLBI
|
5K99HL088017-02
|
|
WalkLink: Email-Based Walking Program for Cardiovascular Disease Risk-Reduction
|
ROVNIAK, LIZA
|
SAN DIEGO STATE UNIVERSITY
|
CA
|
$90,000
|
|
Clinical Trials
|
NIMH
|
5R01MH057727-10
|
|
Enhancing Long-Term Outcome in Child Behavior Disorders
|
KOLKO, DAVID
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$492,344
|
|
Clinical Trials
|
NIMH
|
5K01MH073783-03
|
|
Quality Improvement Methods in Geriatric Mental Health
|
SHEERAN, THOMAS
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$160,861
|
|
Clinical Trials
|
NIMH
|
5K24MH001557-10
|
|
Research In Pediatric Anxiety Disorders
|
MARCH, JOHN
|
DUKE UNIVERSITY
|
NC
|
$136,684
|
|
Clinical Trials
|
NIMH
|
5K23MH073658-03
|
|
Tailoring Depression Treatment Services to Older Adults
|
WITTINK, MARSHA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$180,563
|
|
Clinical Trials
|
NIMH
|
5K23MH065281-05
|
|
Treatment of Late-Life Anxiety in a Primary Care Setting
|
BRENES, GRETCHEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$163,609
|
|
Clinical Trials
|
NIMH
|
5K23MH067710-05
|
|
Intervention to Prevent Post-Stroke Major Depression
|
WHYTE, ELLEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$172,778
|
|
Clinical Trials
|
NIMH
|
5R34MH072678-03
|
|
Combined Treatment for GAD
|
CRITS-CHRISTOPH, PAUL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$206,459
|
|
Clinical Trials
|
NIAID
|
5K23AI067567-03
|
|
Rebuilding immunity
|
AQUI, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$133,029
|
|
Clinical Trials
|
NCI
|
5U01CA062405-14
|
|
NABTC Member Institution Grant (UCSF Project Leader)
|
LIEBERMAN, FRANK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$58,706
|
|
Clinical Trials
|
NCI
|
5U01CA062432-14
|
|
NEW APPLICATIONS IN BRAIN TUMOR THERAPY
|
MIKKELSEN, TOM
|
HENRY FORD HEALTH SYSTEM
|
MI
|
$131,442
|
|
Clinical Trials
|
NIAAA
|
5R01AA015383-03
|
|
Delphi Evaluation of Alcohol Advertising Codes
|
BABOR, THOMAS
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$323,343
|
|
Clinical Trials
|
NCI
|
5R01CA106662-04
|
|
Dendritic Cell Threapy for Cutaneous T-Cell Lymphoma
|
FALO, LOUIS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$288,651
|
|
Clinical Trials
|
NIMH
|
5U01MH070008-03
|
|
Relapse Prevention: Long Acting Atypical Antipsychotics
|
LAURIELLO, JOHN
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$202,446
|
|
Clinical Trials
|
NIMH
|
5R01MH070935-04
|
|
Predicting Response to Atomoxetine and Methlyphenidate
|
NEWCORN, JEFFREY
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$648,558
|
|
Clinical Trials
|
NIMH
|
5K23MH076671-03
|
|
Intervention for HIV+ Adults With Childhood Sexual Abuse
|
HANSEN, NATHAN
|
YALE UNIVERSITY
|
CT
|
$180,457
|
|
Clinical Trials
|
NIMH
|
5R34MH074504-02
|
|
Levels of Cognition in Patient Reported Outcomes
|
SHUMWAY, MARTHA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$208,181
|
|
Clinical Trials
|
NIMH
|
5K23MH074895-02
|
|
Cognitive-Behavior Therapy for Bipolar Disorder
|
DECKERSBACH, THILO
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$184,248
|
|
Clinical Trials
|
NIMH
|
7U01MH070017-03
|
|
Relapse Prevention: Long Acting Atypical Antipsychotics
|
MANSCHRECK, THEO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$192,832
|
|
Clinical Trials
|
NCI
|
5R01CA120381-02
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$367,050
|
|
Clinical Trials
|
NIMH
|
5R01MH069618-05
|
|
Are Cognitive Therapy's Antidepressant Effects Durable?
|
FRIEDMAN, EDWARD
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$285,130
|
|
Clinical Trials
|
NIMH
|
5R01MH073174-04
|
|
Quantification of facial expressions for neuropsychiatry
|
VERMA, RAGINI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$195,870
|
|
Clinical Trials
|
NIDCD
|
5R01DC005972-05
|
|
Randomized Trial of Tinnitus Retraining Therapy
|
TYLER, RICHARD
|
UNIVERSITY OF IOWA
|
IA
|
$314,039
|
|
Clinical Trials
|
NCI
|
5U01CA062474-14
|
|
NEW APPROACHES TO BRAIN TUMOR THERAPY-(NABTT)
|
BREM, HENRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$119,036
|
|
Clinical Trials
|
NIMH
|
5R34MH077503-02
|
|
Antidepressant & Behavioral Adherence Intervention for Depressed HIV Patients
|
WAGNER, GLENN
|
RAND CORPORATION
|
CA
|
$215,153
|
|
Clinical Trials
|
NIMH
|
5K01MH071714-03
|
|
Quality of Care for Bipolar Disorder
|
BUSCH, ALISA
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$177,146
|
|
Clinical Trials
|
NCI
|
5U01CA062407-14
|
|
Therapeutics Studies of Primary CNS Malignancies
|
WEN, PATRICK
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$142,136
|
|
Clinical Trials
|
NHLBI
|
5K24HL074256-04
|
|
Arginine as Prophylactic Therapy in Sickle Cell Disease
|
STYLES, LORI
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
CA
|
$150,118
|
|
Clinical Trials
|
FIC
|
5R03TW007197-02
|
|
Extension of Causal Inference - FIRCA
|
ZHOU, XIAO-HUA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$39,372
|
|
Clinical Trials
|
NIAID
|
5R01AI036525-11
|
|
Immune Mechanisms of Protection in S Typhi Vaccines
|
SZTEIN, MARCELO
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$439,396
|
|
Clinical Trials
|
NIMH
|
5R34MH078719-02
|
|
Reducing Teen Risky Behavior: A Clinic-Based Approach
|
GUILAMO-RAMOS, VINCENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$289,800
|
|
Clinical Trials
|
NIMH
|
5K23MH069784-05
|
|
Patient Preference in Primary Care Depression Treatment
|
RAUE, PATRICK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$142,066
|
|
Clinical Trials
|
NIMH
|
5R01MH070564-05
|
|
Measuring and Predicting Responses to ATX and MPH
|
STEIN, MARK
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$377,592
|
|
Clinical Trials
|
NIMH
|
5U01MH064846-06
|
|
Treatment of Early Age Mania (TEAM)
|
GELLER, BARBARA
|
WASHINGTON UNIVERSITY
|
MO
|
$792,684
|
|
Clinical Trials
|
NIMH
|
5U01MH070007-03
|
|
Relapse Prevention: Long-Acting Atypical Antipsychotics
|
MENDELOWITZ, ALAN
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$270,935
|
|
Clinical Trials
|
NIMH
|
5U01MH070012-03
|
|
Relapse Prevention: Long-Acting Atypical Antipsychotics
|
KOPELOWICZ, ALEX
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$305,865
|
|
Clinical Trials
|
NIMH
|
5R01MH074777-02
|
|
Augmented Treatment of Specific Phobias in Children
|
OLLENDICK, THOMAS
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
VA
|
$229,898
|
|
Clinical Trials
|
NIMH
|
5R01MH074070-03
|
|
Preventable Mortality in Maryland Medicaid SMI
|
DAUMIT, GAIL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$365,695
|
|
Clinical Trials
|
NIMH
|
5K01MH068619-04
|
|
Children of Depressed Mothers: Culture & Prevention
|
BOYD, RHONDA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$141,792
|
|
Clinical Trials
|
NIMH
|
5R34MH074552-02
|
|
School-Based CBT for Anxious African-American Children
|
GINSBURG, GOLDA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$221,400
|
|
Clinical Trials
|
NIMH
|
5K01MH067690-05
|
|
School-Based Mental Health Interventions for Refugees
|
BIRMAN, DINA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$151,856
|
|
Clinical Trials
|
NIDDK
|
5K23DK066165-05
|
|
Screening for Barrett's in Otolaryngology Patients
|
JOBE, BLAIR
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$133,110
|
|
Clinical Trials
|
NIMH
|
5U01MH070023-03
|
|
Relapse Prevention Study: Steering and Implementation
|
KANE, JOHN
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$160,215
|
|
Clinical Trials
|
NIMH
|
5U01MH064868-06
|
|
Treatment of Early Age Mania (TEAM)
|
LUBY, JOAN
|
WASHINGTON UNIVERSITY
|
MO
|
$395,330
|
|
Clinical Trials
|
NIMH
|
5U01MH064850-06
|
|
Treatment of Early Age Mania
|
WAGNER, KAREN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$355,684
|
|
Clinical Trials
|
NIAID
|
5R01AI065348-03
|
|
Metabolic Consequences of Thymidine Sparing Regimens
|
MCCOMSEY, GRACE
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$212,681
|
|
Clinical Trials
|
NIDDK
|
5K23DK073536-03
|
|
Addressing emotional and cognitive factors in behavioral weight loss treatment
|
NIEMEIER, HEATHER
|
MIRIAM HOSPITAL
|
RI
|
$152,702
|
|
Clinical Trials
|
NHLBI
|
5R01HL075893-04
|
|
Trial of Asthma Patient Education in the Emergency Room
|
MANCUSO, CAROL
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$419,539
|
|
Clinical Trials
|
NIAAA
|
5R01AA015950-03
|
|
Treatment of Suicide in Alcoholic and Depressed Patients
|
MILLER, IVAN
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
RI
|
$317,663
|
|
Clinical Trials
|
NIMH
|
5U01MH070009-03
|
|
Relapse Prevention: Long-Acting Atypical Antipsychotics
|
GOFF, DONALD
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$203,402
|
|
Clinical Trials
|
NICHD
|
5R01HD043869-05
|
|
Effects of Adrenal and Gonadal HR in Young Women with AN
|
GORDON, CATHERINE
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$254,410
|
|
Clinical Trials
|
NCI
|
5R01CA066218-28
|
|
Statistical Methods for Cancer Research
|
TURNBULL, BRUCE
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$160,546
|
|
Clinical Trials
|
NIMH
|
5R01MH070831-02
|
|
Folate in Schizophrenia
|
GOFF, DONALD
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$283,500
|
|
Clinical Trials
|
NIAID
|
5U01AI069441-02
|
|
Baylor College of Medicine Clinical Trial Unit
|
SHEARER, WILLIAM
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$954,755
|
|
Clinical Trials
|
NIAAA
|
5R01AA015056-03
|
|
An Internet-based intervention for problem drinking
|
CUNNINGHAM, JOHN
|
CENTRE FOR ADDICTION AND MENTAL HEALTH
|
CANADA
|
$94,381
|
|
Clinical Trials
|
NIMH
|
5R01MH066347-05
|
|
Effectiveness of PTSD Treatment: Prolonged Exposure Therapy vs. Zoloft
|
ZOELLNER, LORI
|
UNIVERSITY OF WASHINGTON
|
WA
|
$360,557
|
|
Clinical Trials
|
NIMH
|
5R01MH066348-05
|
|
Effectiveness of Posttraumatic Stress Disorder Treatment: PE vs Zoloft
|
FEENY, NORAH
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$289,931
|
|
Clinical Trials
|
NIMH
|
5R01MH058820-06
|
|
Delivering CBT to Patients with BN in Rural Settings
|
MITCHELL, JAMES
|
NEUROPSYCHIATRIC RESEARCH INSTITUTE
|
ND
|
$104,263
|
|
Clinical Trials
|
NIMH
|
5R01MH071580-03
|
|
IL-2 Neuropsychiatric Symptoms: Mechanisms, Prevention
|
MUSSELMAN, DOMINIQUE
|
EMORY UNIVERSITY
|
GA
|
$300,841
|
|
Clinical Trials
|
NIMH
|
5U01MH070010-03
|
|
Relapse Prevention: Long-Acting Atypical Antipsychotics
|
MILLER, DEL
|
UNIVERSITY OF IOWA
|
IA
|
$238,108
|
|
Clinical Trials
|
NIMH
|
5U01MH064869-06
|
|
Treatment of Early Age Mania Study
|
WALKUP, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$539,243
|
|
Clinical Trials
|
NIMH
|
5R01MH074374-03
|
|
Specialized services for high-risk birth parents
|
DOZIER, MARY
|
UNIVERSITY OF DELAWARE
|
DE
|
$638,765
|
|
Clinical Trials
|
NIMH
|
5U01MH064887-06
|
|
Treatment of Early Age Mania (TEAM)
|
JOSHI, PARAMJIT
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$404,112
|
|
Clinical Trials
|
NIMH
|
5U01MH070011-03
|
|
Relapse Prevention: Long-Acting Atypical Antipsychotics
|
BUCKLEY, PETER
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$218,053
|
|
Clinical Trials
|
NCI
|
5U24CA075362-11
|
|
IBCSG STATISTICAL CENTER--A BREAST CANCER STUDY RESOURCE
|
GELBER, RICHARD
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$462,685
|
|
Clinical Trials
|
NIMH
|
5K01MH079093-02
|
|
The Complexity of Late Life Depression: Bridging Methods and Clinical Substance
|
BYERS, AMY
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$111,613
|
|
Clinical Trials
|
NIMH
|
5R01MH065963-05
|
|
Short-Term vs Long-Term Treatment for GAD
|
RICKELS, KARL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$434,603
|
|
Clinical Trials
|
NIMH
|
5R01MH076136-02
|
|
The neural bases of placebo effects and their relation to regulatory processes
|
WAGER, TOR
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$357,113
|
|
Clinical Trials
|
NIMH
|
5K23MH076976-02
|
|
Negative Symptoms of Schizophrenia: From Phenomenology to Targeted Treatment
|
STANFORD, ARIELLE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$177,055
|
|
Clinical Trials
|
NHLBI
|
5U01HL087314-02
|
|
Northeast Ohio Center for Cardiovascular Cell Therapy Research
|
ELLIS, STEPHEN
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$438,330
|
|
Clinical Trials
|
NCI
|
5R21CA125227-02
|
|
Microvascular Perfusion Sonographic Imaging to Detect Early Stage Ovarian Cancer
|
FISHMAN, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$164,859
|
|
Clinical Trials
|
NHLBI
|
5U01HL087318-02
|
|
Cardiovascular Cell Therapy Research Network - Data Coordinating Center
|
MOYE, LEMUEL
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$3,877,311
|
|
Clinical Trials
|
NHLBI
|
5U01HL087365-02
|
|
Cardiovascular Cell Therapy Research Network
|
WILLERSON, JAMES
|
TEXAS HEART INSTITUTE
|
TX
|
$378,066
|
|
Clinical Trials
|
NHLBI
|
5U01HL087366-02
|
|
UFCC for Cardiovascular Cell Therapy Research Network
|
PEPINE, CARL
|
UNIVERSITY OF FLORIDA
|
FL
|
$537,223
|
|
Clinical Trials
|
NHLBI
|
5U01HL087394-02
|
|
MN Cardiovascular Cell Therapy Clinical Research Network: From AMI to CHF
|
HENRY, TIMOTHY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$353,027
|
|
Clinical Trials
|
NHLBI
|
5U01HL087403-02
|
|
Cell Therapy for Improving Cardiac Function
|
ZHAO, DAVID
|
VANDERBILT UNIVERSITY
|
TN
|
$527,149
|
|
Clinical Trials
|
NICHD
|
5U01HD033343-14
|
|
Data Acquisition and Analysis Center for Behavioral Res*
|
HOUTS, RENATE
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$1,706,273
|
|
Clinical Trials
|
NIMH
|
5R34MH077282-02
|
|
A Psychiatric Rehabilitation Approach to Weight Loss
|
HAMERA, EDNA
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$205,065
|
|
Clinical Trials
|
NIMH
|
1R01MH086160-01
|
|
Adolescent Women & microbicide Trials: Assessing the Challenges and Opportunities
|
TOLLEY, ELIZABETH
|
FAMILY HEALTH INTERNATIONAL
|
NC
|
$409,591
|
|
Clinical Trials
|
NCI
|
5R01CA128187-02
|
|
Meaning-Centered Group Psychotherapy in Advanced Cancer
|
BREITBART, WILLIAM
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$418,640
|
|
Clinical Trials
|
NIAAA
|
5R01AA007850-18
|
|
Biobehavioral mechanisms of topiramate and drinking
|
MONTI, PETER
|
BROWN UNIVERSITY
|
RI
|
$557,621
|
|
Clinical Trials
|
NIAID
|
5U01AI069502-02
|
|
UCSF HIV Clinical Trials Unit
|
HAVLIR, DIANE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$1,028,280
|
|
Clinical Trials
|
NIAID
|
5U01AI069536-02
|
|
University of California, San Diego Clinical Trial Unit
|
SPECTOR, STEPHEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$1,127,587
|
|
Clinical Trials
|
NIAID
|
5U01AI069434-02
|
|
UW Clinical HIV Integrated Research Program
|
COLLIER, ANN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$1,157,590
|
|
Clinical Trials
|
NIDDK
|
5K23DK066248-05
|
|
The Natural History of Pediatric Crohn's Disease
|
DUBINSKY, MARLA
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$124,362
|
|
Clinical Trials
|
NIAAA
|
5R01AA014976-03
|
|
Tailored Web Program to Reduce At-Risk College Drinking
|
BINGHAM, C. RAYMOND
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$514,353
|
|
Clinical Trials
|
NIDDK
|
5R01DK058785-06
|
|
Role of leptin in the neuroendocrine response to fasting
|
MANTZOROS, CHRISTOS
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$366,520
|
|
Clinical Trials
|
NCI
|
5R01CA116576-02
|
|
Tailored Navigation in CRC Screening
|
MYERS, RONALD
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$530,038
|
|
Clinical Trials
|
NIDCR
|
5R01DE013814-07
|
|
Functional Outcomes of Cleft Lip Surgery
|
TROTMAN, CARROLL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$485,391
|
|
Clinical Trials
|
NCI
|
5U01CA105663-05
|
|
Participating Member Institution in NABTC
|
DEANGELIS, LISA
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$169,613
|
|
Clinical Trials
|
NCI
|
5U01CA062412-14
|
|
NABTC - M.D. Anderson Clinical Center
|
GILBERT, MARK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$141,872
|
|
Clinical Trials
|
NCI
|
5U01CA105689-05
|
|
Phamacokinetics Center for the NABTT CNS Consortium
|
SUPKO, JEFFREY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$189,873
|
|
Clinical Trials
|
NCI
|
5U01CA105706-05
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$70,948
|
|
Clinical Trials
|
NIAID
|
5R01AI068107-03
|
|
A community-level RCT of expedited partner treatment for gonorrhea and chlamydia
|
GOLDEN, MATTHEW
|
UNIVERSITY OF WASHINGTON
|
WA
|
$592,031
|
|
Clinical Trials
|
NCI
|
5R01CA116673-02
|
|
Clinical Trial of Selenium and Prostate Biomarkers
|
MARSHALL, JAMES
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$410,787
|
|
Clinical Trials
|
NIDDK
|
5R01DK034108-22
|
|
Pulmonary Benefits of Cystic Fibrosis Neonatal Screening
|
FARRELL, PHILIP
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$496,723
|
|
Clinical Trials
|
NIAID
|
5U01AI069419-02
|
|
Cornell Clinical Trials Unit
|
GULICK, ROY
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$1,184,443
|
|
Clinical Trials
|
NINDS
|
5K23NS048152-04
|
|
Neurological Diseases Research in High Risk Newborns
|
PARIKH, NEHAL
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$162,869
|
|
Clinical Trials
|
NIMH
|
5R01MH077524-02
|
|
Integrating HIV Prevention into Clinical Care for PLWHA in South Africa
|
FISHER, JEFFREY
|
UNIVERSITY OF CONNECTICUT STORRS
|
CT
|
$1,377,153
|
|
Clinical Trials
|
NIDDK
|
5R37DK035524-22
|
|
Linking Self-Management and Primary Care for Diabetes
|
GLASGOW, RUSSELL
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$601,663
|
|
Clinical Trials
|
NIMH
|
5K23MH076934-02
|
|
Interpersonal Psychotherapy for Body Dysmorphic Disorder
|
DIDIE, ELIZABETH
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
RI
|
$177,922
|
|
Clinical Trials
|
NCI
|
5U01CA062406-14
|
|
NABTT-New Approaches to Brain Tumor Therapy (CNSC)
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$57,838
|
|
Clinical Trials
|
NIMH
|
5K23MH074716-02
|
|
Implementing an Evidence-Based Treatment for Child Abuse
|
HERSCHELL, AMY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$137,835
|
|
Clinical Trials
|
NIMH
|
5K23MH077225-02
|
|
A Medication Adherence Intervention for Older Adults with Bipolar Disorder
|
DEPP, COLIN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$151,614
|
|
Clinical Trials
|
NICHD
|
5R01HD045362-05
|
|
Comprehensive Elementary School Risk Prevention
|
SCHONFELD, DAVID
|
YALE UNIVERSITY
|
CT
|
$531,733
|
|
Clinical Trials
|
NIAID
|
5U01AI069532-02
|
|
New York University HIV/AIDS Clinical Trial Unit
|
ABERG, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$1,488,404
|
|
Clinical Trials
|
NIAID
|
5U01AI069474-02
|
|
The Ohio State University AIDS Clinical Trials Unit
|
KOLETAR, SUSAN
|
OHIO STATE UNIVERSITY
|
OH
|
$2,542,078
|
|
Clinical Trials
|
NIMH
|
5K23MH067895-05
|
|
A Services Intervention for Homeless with Schizophrenia
|
FOLSOM, DAVID
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$170,224
|
|
Clinical Trials
|
NIDDK
|
5K24DK076808-02
|
|
Patient Oriented Research in Vitamin D and Physical Functioning in CKD
|
LEONARD, MARY
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$169,601
|
|
Clinical Trials
|
NINDS
|
5K23NS051202-03
|
|
Treatment of Obstructive Sleep Apnea After Stroke
|
BROWN, DEVIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$167,648
|
|
Clinical Trials
|
NIDDK
|
5R01DK073025-03
|
|
Reducing Sugar-Sweetened Beverage Consumption in Overweight Adolescents
|
LUDWIG, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$730,053
|
|
Clinical Trials
|
NIMH
|
5K23MH074079-03
|
|
Maternal Depression and Early Head Start
|
SILVERSTEIN, MICHAEL
|
BOSTON MEDICAL CENTER
|
MA
|
$163,666
|
|
Clinical Trials
|
NHLBI
|
5R01HL053353-11
|
|
Genetics of Hypertension in Blacks
|
COOPER, RICHARD
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$402,431
|
|
Clinical Trials
|
NINDS
|
5U01NS045803-05
|
|
Childhood Absence Epilepsy: Coordinating Center
|
CNAAN, AVITAL
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$760,344
|
|
Clinical Trials
|
NHLBI
|
5R01HL080664-03
|
|
Exercise, Depression, and Cardiac Risk
|
BLUMENTHAL, JAMES
|
DUKE UNIVERSITY
|
NC
|
$741,047
|
|
Clinical Trials
|
NIAID
|
5U01AI069513-02
|
|
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
|
FICHTENBAUM, CARL
|
UNIVERSITY OF CINCINNATI
|
OH
|
$1,699,965
|
|
Clinical Trials
|
NIMH
|
5R34MH073554-03
|
|
Treatment of Child Anxiety in Pediatric Medical Settings
|
MASIA, CARRIE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$221,807
|
|
Clinical Trials
|
NINDS
|
5U01NS051566-03
|
|
A Randomized Trial of Unruptured Brain AVMs (ARUBA)-STAT
|
MOSKOWITZ, ALAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$600,000
|
|
Clinical Trials
|
NIMH
|
5R01MH054248-12
|
|
Follow Up of a Randomized Trial for Conduct Disorders (CD)
|
EDDY, JOHN
|
OREGON SOCIAL LEARNING CENTER, INC.
|
OR
|
$554,926
|
|
Clinical Trials
|
NINDS
|
5R01NS048212-04
|
|
Study of Carotid Occlusion and Neurocognition (RECON)
|
MARSHALL, RANDOLPH
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$395,801
|
|
Clinical Trials
|
NIAID
|
5U01AI069418-02
|
|
Emory HIV/AIDS Clinical Trials Unit
|
LENNOX, JEFFREY
|
EMORY UNIVERSITY
|
GA
|
$3,002,959
|
|
Clinical Trials
|
OD
|
5U01AI069418-02
|
|
Emory HIV/AIDS Clinical Trials Unit
|
LENNOX, JEFFREY
|
EMORY UNIVERSITY
|
GA
|
$250,000
|
|
Clinical Trials
|
NCI
|
5U01CA105695-05
|
|
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies
|
CLOUGHESY, TIMOTHY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$146,647
|
|
Clinical Trials
|
NIMH
|
5U01MH064851-06
|
|
Treatment of Early-Age Mania
|
AXELSON, DAVID
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$432,904
|
|
Clinical Trials
|
NINDS
|
5R01NS050151-04
|
|
Glioblastoma - Molecular Analysis for Clinical Trials
|
MISCHEL, PAUL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$338,768
|
|
Clinical Trials
|
NHLBI
|
5K23HL086558-02
|
|
Metabolic Effects of Antihypertensive Drugs
|
COOPER-DEHOFF, RHONDA
|
UNIVERSITY OF FLORIDA
|
FL
|
$150,962
|
|
Clinical Trials
|
NIAID
|
5U01AI069556-02
|
|
Stanford AIDS Clinical Trials Unit
|
ZOLOPA, ANDREW
|
STANFORD UNIVERSITY
|
CA
|
$816,602
|
|
Clinical Trials
|
NIAID
|
5U01AI069412-02
|
|
Harvard Medical School Vaccine Clinical Trials Unit
|
DOLIN, RAPHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$977,281
|
|
Clinical Trials
|
NCI
|
5U01CA062422-14
|
|
NABTC Member Intitution Grant (UCSF Project Leader)
|
CHANG, SUSAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$138,276
|
|
Clinical Trials
|
NIAID
|
5U01AI069450-02
|
|
Colorado AIDS Clinical Trials Unit
|
CAMPBELL, THOMAS
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$1,461,810
|
|
Clinical Trials
|
NIAID
|
5U01AI069534-02
|
|
Penn prevention clinical trials unit
|
METZGER, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$1,568,547
|
|
Clinical Trials
|
NIMH
|
5U01MH070016-03
|
|
Relapse Prevention: Long-Acting Atypical Antipsychotics
|
WILSON, DANIEL
|
CREIGHTON UNIVERSITY
|
NE
|
$205,798
|
|
Clinical Trials
|
NIAAA
|
5R01AA016117-02
|
|
Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence
|
BROWER, KIRK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$383,502
|
|
Clinical Trials
|
NCI
|
5R01CA118663-02
|
|
Storytelling for Colorectal Health among Latinos
|
LARKEY, LINDA
|
UNIVERSITY OF ARIZONA
|
AZ
|
$515,557
|
|
Clinical Trials
|
NCI
|
5U10CA011488-38
|
|
EORTC DATA CENTER
|
SYLVESTER, RICHARD
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
BELGIU
|
$793,241
|
|
Clinical Trials
|
NIAID
|
5U01AI064002-04
|
|
Chemoprophylaxis for HIV Prevention in Men
|
GRANT, ROBERT
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$5,141,967
|
|
Clinical Trials
|
NIDDK
|
5R44DK071369-03
|
|
MethLock vs. heparin as dialysis catheter lock
|
ASH, STEPHEN
|
ASH ACCESS TECHNOLOGY, INC.
|
IN
|
$899,370
|
|
Clinical Trials
|
FIC
|
1K01TW008016-01
|
|
Conditional Cash Transfers to Prevent Sexually Transmitted Infections in Mexico
|
GALARRAGA, OMAR
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$119,241
|
|
Clinical Trials
|
NIMH
|
5R01MH067792-05
|
|
Prevention for Infants of Low-Income Depressed Mothers
|
TOTH, SHEREE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$498,322
|
|
Clinical Trials
|
NIDCR
|
5U01DE014338-06
|
|
Effects of Periodontal Therapy on Preterm Birth
|
MICHALOWICZ, BRYAN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$935,159
|
|
Clinical Trials
|
NIMH
|
5R01MH077541-02
|
|
High-risk Establishments and Women's HIV Prevention in Southern China
|
WEEKS, MARGARET
|
INSTITUTE FOR COMMUNITY RESEARCH
|
CT
|
$464,406
|
|
Clinical Trials
|
NIAID
|
5R01AI060892-05
|
|
Douching Prevention Trial in Mother-Daughter Dyads
|
ROMPALO, ANNE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$474,813
|
|
Clinical Trials
|
NINR
|
5R01NR007765-05
|
|
Effect of a Pain Protocol on Discomfort in Dementia
|
KOVACH, CHRISTINE
|
UNIVERSITY OF WISCONSIN MILWAUKEE
|
WI
|
$491,051
|
|
Clinical Trials
|
NINR
|
5R01NR010004-03
|
|
HIV Testing and Women's Attitudes on HIV Vaccine Trials
|
ZIMET, GREGORY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$514,060
|
|
Clinical Trials
|
NICHD
|
5K23HD048817-04
|
|
Improving Drug Development for the Critically Ill Child
|
ZUPPA, ATHENA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$132,472
|
|
Clinical Trials
|
NCI
|
5R01CA116242-02
|
|
Tea Polyphenols in Chemoprevention of Prostate Cancer
|
HENNING, SUSANNE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$264,195
|
|
Clinical Trials
|
NICHD
|
5K24HD042489-05
|
|
Appropriate Use of Oral Antibiotics in Children
|
BAUCHNER, HOWARD
|
BOSTON MEDICAL CENTER
|
MA
|
$142,383
|
|
Clinical Trials
|
NIMH
|
5K24MH001571-09
|
|
Cognitive Therapy for High Risk & Refractory Depression
|
JARRETT, ROBIN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$128,156
|
|
Clinical Trials
|
NIAID
|
5U01AI069415-02
|
|
University of Puerto Rico Clinical Trials Unit
|
ZORRILLA, CARMEN
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$2,320,253
|
|
Clinical Trials
|
NIAID
|
5U01AI069472-02
|
|
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
|
KURITZKES, DANIEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$3,009,817
|
|
Clinical Trials
|
NIBIB
|
2R01EB002138-06
|
|
Breast CT scanner for earlier cancer detection
|
BOONE, JOHN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$1,093,701
|
|
Clinical Trials
|
NIMH
|
5R01MH068468-04
|
|
Multifaceted Depression Diabetes Program for Hispanics
|
ELL, KATHLEEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$683,969
|
|
Clinical Trials
|
NIDDK
|
5U01DK056957-08
|
|
Polycystic Kidney Disease: Innovative Imaging to Assess Progression (PCC)
|
TORRES, VICENTE
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$369,513
|
|
Clinical Trials
|
NIDDK
|
5U01DK056956-08
|
|
"The Early Collaborative Clinical Studies in PKD: The C*
|
CHAPMAN, ARLENE
|
EMORY UNIVERSITY
|
GA
|
$337,438
|
|
Clinical Trials
|
NIAID
|
5U01AI069443-02
|
|
South-West European HIV Vaccine Clinical Trial Unit
|
PANTALEO, GIUSEPPE
|
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
|
SWITZE
|
$369,932
|
|
Clinical Trials
|
NIDDK
|
5U01DK056961-09
|
|
Data Coordinating and Image Analysis for CRISP-II
|
BAE, KYONGTAE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$428,981
|
|
Clinical Trials
|
NIDDK
|
5R01DK072932-02
|
|
Targeted Obesity Prevention Program for Adolescent Females
|
STICE, ERIC
|
OREGON RESEARCH INSTITUTE
|
OR
|
$524,075
|
|
Clinical Trials
|
NIAID
|
5U01AI069529-02
|
|
St. Jude/Memphis IMPAACT Clinical Trials Unit
|
FLYNN, PATRICIA
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$977,266
|
|
Clinical Trials
|
NIMH
|
5R34MH077500-02
|
|
Adapting MST to Address Transmission Risk Behaviors in HIV+ Young People
|
LETOURNEAU, ELIZABETH
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$268,460
|
|
Clinical Trials
|
NIMH
|
5R01MH073673-03
|
|
rTMS Clinical Trial for Auditory Hallucinations
|
HOFFMAN, RALPH
|
YALE UNIVERSITY
|
CT
|
$424,822
|
|
Clinical Trials
|
NIMH
|
5R01MH070547-04
|
|
Pharmacotherapy of Latelife Generalized Anxiety Disorder
|
BUTTERS, MERYL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$288,651
|
|
Clinical Trials
|
NIAID
|
5U01AI069537-02
|
|
NJMS Clinical Trials Unit: Targeting Pediatric, Adolescent, and Material HIV Infe
|
OLESKE, JAMES
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$663,233
|
|
Clinical Trials
|
NIAID
|
5U01AI069516-02
|
|
Western New England Maternal Pediatric Adolescent AIDS Clinical Trials Unit
|
LUZURIAGA, KATHERINE
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$741,810
|
|
Clinical Trials
|
NIMH
|
5R01MH069806-02
|
|
Practice Redesign to Improve Depression Care - PRIDE Care
|
WEST, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$291,300
|
|
Clinical Trials
|
NIAAA
|
5R01AA008972-15
|
|
Recovery & Help-Seeking Processes in Problem Drinkers
|
TUCKER, JALIE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$481,036
|
|
Clinical Trials
|
NHLBI
|
2U54HL070587-06
|
|
Statistics and Data Management Center-Comprehensive Sickle Cell Centers
|
KESLER, KAREN
|
RHO FEDERAL SYSTEMS DIVISION, INC.
|
NC
|
$3,400,108
|
|
Clinical Trials
|
NIMH
|
2P30MH043520-20
|
9007
|
Statistics, Epidemiology, and Data Management Core
|
LEVIN, BRUCE
|
RESEARCH FOUNDATION FOR MENTAL HYGIENE
|
NY
|
$373,364
|
|
Clinical Trials
|
NEI
|
5K23EY017897-02
|
|
Predicting and Improving Clinical Outcomes for Bacterial Keratitis
|
ACHARYA, NISHA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$208,411
|
|
Clinical Trials
|
NIMH
|
5R34MH073796-03
|
|
Development of CBT Model for Adolescent Bulimia Nervosa
|
DEBAR, LYNN
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$276,152
|
|
Clinical Trials
|
NCI
|
5R21CA114547-02
|
|
Intervention to Enhance Quality of Life in Men with PCa: Development and Testing
|
ELLER, LUCILLE
|
RUTGERS THE STATE UNIV OF NJ NEWARK
|
NJ
|
$154,500
|
|
Clinical Trials
|
NIAID
|
5U01AI069467-02
|
|
Philadelphia IMPAACT Clinical Trials Unit
|
DOUGLAS, STEVEN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$1,674,252
|
|
Clinical Trials
|
NINR
|
5R01NR009295-03
|
|
Reducing Sedative Exposure in Ventilated ICU Patients
|
CHLAN, LINDA
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$430,683
|
|
Clinical Trials
|
NIMH
|
5K23MH076049-03
|
|
Fluoxetine Versus Bupropion in Suicide Attempters With Major Depressive Disorder
|
GRUNEBAUM, MICHAEL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$176,861
|
|
Clinical Trials
|
NIAID
|
5U01AI069413-02
|
|
Bronx-Lebanon Hospital Clinical Trials Unit
|
PURSWANI, MURLI
|
BRONX-LEBANON HOSP CTR (BRONX, NY)
|
NY
|
$712,045
|
|
Clinical Trials
|
NCI
|
5R01CA120594-02
|
|
Smoking topography and harm exposure in a new PREP
|
STRASSER, ANDREW
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$287,924
|
|
Clinical Trials
|
NIAID
|
5U01AI069554-02
|
|
Targeting High-Risk Women for HVTN and Microbicide Trials
|
NOVAK, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$596,555
|
|
Clinical Trials
|
NIAAA
|
5K24AA015320-04
|
|
Psychopathology in Pharmacotherapy of AUD/MDD Teens
|
CORNELIUS, JACK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$117,678
|
|
Clinical Trials
|
NIMH
|
5K01MH073903-02
|
|
Measurement Error in Latent Class Models of Adherence
|
MORALES, KNASHAWN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$137,845
|
|
Clinical Trials
|
NIAID
|
5U01AI069495-02
|
|
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT
|
CLIFFORD, DAVID
|
WASHINGTON UNIVERSITY
|
MO
|
$2,050,805
|
|
Clinical Trials
|
NIAID
|
5U01AI069423-02
|
|
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
|
ERON, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$2,899,686
|
|
Clinical Trials
|
NIAAA
|
5R01AA014963-04
|
|
Enhancing EP-Performed Alcohol Interventions in the ED
|
D'ONOFRIO, GAIL
|
YALE UNIVERSITY
|
CT
|
$666,627
|
|
Clinical Trials
|
NIDCD
|
5R01DC007893-03
|
|
Stuttering Therapy and Neurophysiological Interaction
|
INGHAM, ROGER
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$464,817
|
|
Clinical Trials
|
NIAID
|
5U01AI069481-02
|
|
Seattle Vaccine Trials Unit
|
MCELRATH, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$561,625
|
|
Clinical Trials
|
NIAID
|
5U01AI069470-02
|
|
Columbia Collaborative HIV/AIDS Clinical Trials Unit
|
HAMMER, SCOTT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$2,878,282
|
|
Clinical Trials
|
NINDS
|
5R01NS051623-03
|
|
Novel MRI and 1H-MRS markers in Primary Progressive MS
|
INGLESE, M
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$369,223
|
|
Clinical Trials
|
NIBIB
|
5R01EB003540-04
|
|
Polarization Spectroscopy and Imaging of Pre-Cancer
|
SOKOLOV, KONSTANTIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$238,661
|
|
Clinical Trials
|
NIAID
|
5U01AI069511-02
|
|
Units for HIV/AIDS Clinical Trials Networks
|
KEEFER, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$2,248,523
|
|
Clinical Trials
|
NIMH
|
5R34MH076935-02
|
|
Domestic Violence: An Emotion Coaching Parenting Intervention
|
KATZ, LYNN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$164,383
|
|
Clinical Trials
|
NHLBI
|
5R01HL075538-05
|
|
Disclosing Conflict of Interest to Research Participants
|
SUGARMAN, JEREMY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$401,675
|
|
Clinical Trials
|
NIAID
|
5U01AI069409-02
|
|
HIV/AIDS Clinical Trials in Jamaica
|
FIGUEROA, JOHN
|
JAMAICA MINISTRY OF HEALTH
|
JAMAIC
|
$461,901
|
|
